Xingqi Eye Medicine (300573.SZ) released its first quarter results, with a net profit attributable to the parent company of 146 million yuan, an increase of 319.86%.

Wisdom Financial APP news, Xingqi Eye Medicine (300573.SZ) released its first quarter report for 2025, with the company's operating income reaching 536 million yuan, a year-on-year increase of 53.24%. Net profit attributable to shareholders of the listed company was 146 million yuan, a year-on-year increase of 319.86%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 136 million yuan, a year-on-year increase of 285.96%. Basic earnings per share were 0.83 yuan.